首页> 外文期刊>NanoBioscience, IEEE Transactions on >Towards an Endpoint Cell Motility Assay by a Microfluidic Platform
【24h】

Towards an Endpoint Cell Motility Assay by a Microfluidic Platform

机译:通过微流控平台实现终点细胞运动测定

获取原文
获取原文并翻译 | 示例

摘要

In vitro cell motility assays are frequently used in the study of cell migration in response to anti-cancer drug treatment. Microfluidic systems represent a unique tool for the in vitro analysis of cell motility. However, they usually rely on using time-lapse microscopy to record the spatial temporal locations of the individual cells being tested. This has created a bottleneck for microfluidic systems to perform high-throughput experiments due to requirement of a costly time-lapse microscopy system. Here, we describe the development of a portable microfluidic device for endpoint analysis of cell motility. The reported device incorporates a cell alignment feature to position the seeded cells on the same initial location, so that the cells' motilities can be analyzed based on their locations at the end of the experiment after the cells have migrated. We show that the device was able to assess cancer cell motility after treatment with a migration inhibitory drug Indole-3-carbinol on MDA-MB-231 breast cancer cells, demonstrating the applicability of our device in screening anti-cancer drug compounds on cancer cells.
机译:体外细胞运动分析常用于研究细胞迁移对抗癌药物的反应。微流体系统代表了一种用于细胞运动体外分析的独特工具。但是,他们通常依靠使用延时显微镜来记录所测试的单个细胞的空间时间位置。由于需要昂贵的延时显微镜系统,这为微流体系统执行高通量实验创造了瓶颈。在这里,我们描述了用于细胞运动终点分析的便携式微流控设备的开发。报告的设备结合了细胞对齐功能,可将播种的细胞定位在相同的初始位置,以便在细胞迁移后根据实验结束时的位置分析细胞的能动性。我们显示该设备在MDA-MB-231乳腺癌细胞上用迁移抑制药物Indole-3-carbinol治疗后能够评估癌细胞的运动,证明了我们的设备在筛选癌细胞上的抗癌药物化合物中的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号